FDA Adverse Event Malfunction Summary report: N

COULTER HMX HEMATOLOGY ANALYZER

MDR report key: 2253217 · Received September 9, 2011

Report

Report Number
1061932-2011-01379
Event Type
Malfunction
Date Received
September 9, 2011
Date of Event
April 10, 2009
Report Date
April 10, 2009
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
K010765
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW CONDUCTED BETWEEN (B)(4) 2008 AND (B)(4) 2010 OF COMPLAINTS FOR ADD¿L REPORTABLE EVENTS. THIS MDR IS FOR PT 1 OF 1 ON ANALYZER 2 OF 2. SEE MDR # 1061932-2011-01378 FOR PT 1 OF 1 ON ANALYZER 2. THIS APPEARED TO BE A SAMPLE SPECIFIC ISSUE WHERE NRBCS (NUCLEATED RED BLOOD CELLS) WERE NOTED TO BE AS LARGE AS LYMPHOCYTES. PER BECKMAN COULTER INC LABELING, NRBCS ARE A KNOWN INTERFERING SUBSTANCE FOR WHITE BLOOD CELL COUNTS AND VERY SMALL OR MULTI-POPULATION LYMPHOCYTES CAN INTERFERE WITH NRBC IDENTIFICATION. RAW DATA FROM TESTING ON THE HMX ANALYZER WERE NOT PROVIDED FOR ANALYSIS. FIELD SERVICE WAS NOT DISPATCHED FOR THIS EVENT.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT THE HMX HEMATOLOGY ANALYZER DID NOT FLAG FOR NRBC (NUCLEATED RED BLOOD CELLS) OR CORRECT THE WBC (WHITE BLOOD CELL) COUNT ON ONE PT SAMPLE. THE SAMPLE WAS RUN ON THE HMX ANALYZER AND HAS A WBC COUNT TO 45.0 X 10^3. THE TEST RESULTS WERE ACCOMPANIED BY INSTRUMENT-GENERATED MESSAGES. A MANUAL DIFFERENTIAL WAS PERFORMED ON THE SAMPLE. THIRTY NRBCS WERE COUNTED AND THE WBC COUNT WAS ESTIMATED TO BE 30 X 10^3. THE CUSTOMER NOTED THAT SOME NUCLEATED RED BLOOD CELLS WERE AS LARGE AS SMALL LYMPHOCYTES. THE ERRONEOUS TEST RESULTS WERE NOT REPORTED OUT OF THE LAB. THERE WERE NO REPORTED CHANGES TO PT TREATMENT ASSOCIATED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER HMX HEMATOLOGY ANALYZER GKZ BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 50 YR